Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: pappy who wrote (583)	4/3/1998 10:08:00 AM
From: E	Read Replies (3) \| Respond to of 4140

To all: I'd like to hear comments on the Novatec posting by pappy. Thanks.

To: pappy who wrote (583)	4/4/1998 8:16:00 AM
From: EmuGreg	Read Replies (1) \| Respond to of 4140

Pappy, can you help this poor ol' farmer understand a few points re Novatec? 1. Novatec is an ablative laser. For hyperopia, what technique is Novatec currently using to LENGTHEN the eye when the effect of its laser is to remove cells? Is it creating a trough around the cornea similar to what has been attempted with the excimer lasers? If so, what has been the healing response? 2. What level of skill will be required of the opthamologist performing the procedure to correct hyperopia with the Novatec laser? Will it be only the very elite Drs. that can perform it or will virtually any Dr. be able to perform the procedure? 3. The Novatec Web site indicates that it is in Phase IIa trials for myopia. What is the projected time table for the hyperopia trials (start and completion) with the Novatec laser? 4. What are your thoughts as to how the evolution of the Implantable Contact Lens (ICL) will affect the market for ablative lasers in the myopia market? 5. Will there be a software add-on required to do hyperopia with the Novatec laser and, if so, how expensive will it be. 6. When does the FDA permit the fellow eye to be treated with the Novatec laser? 7. What has been the rate (i.e., patients per month) that have been signing up to participate in the Novatec trials. Thank you for your insights into these issues. Best regards. Greg